The best part of this announcement is that if the screening of patient 3 and 4 goes well, then we will have completed the cohort for minimum dose and can now begin to look at higher dosage trials.
The higher dosage trials will hopefully also bring with them some indications regarding efficacy too..
Very happy to see boxes ticked
- Forums
- ASX - By Stock
- Ann: Second Patient In Human Cancer Trial Begins Treatment
The best part of this announcement is that if the screening of...
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $98.34M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $86.20K | 429.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 67508 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 36444 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 47508 | 0.195 |
6 | 238826 | 0.190 |
12 | 723520 | 0.185 |
6 | 377800 | 0.180 |
5 | 151797 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 36444 | 3 |
0.205 | 21529 | 1 |
0.210 | 107676 | 2 |
0.215 | 154400 | 2 |
0.220 | 190000 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online